Orthobiologics technology company Bone Solutions has received FDA 510(k) clearance for its Mg Osteorevive bone void filler, according to a Feb. 2 news release shared with Becker’s.
Mg Osteorevive is a moldable, magnesium-based injectable for use in posterolateral spine fusion procedures. The company said it chose magnesium as the key component for its product because of its strength and elasticity that closely resembles human bone.
The product is being distributed to facilities and surgical centers nationwide for immediate clinical use, the Colleyville, Texas-based company said.
Centinel Spine, a global medical device company, reported a 33% increase in year-over-year revenue during the first quarter of 2025. …
Aurora Spine reported $17.6 million in revenue during fiscal year 2024, an increase of more than 20% over the previous…
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and…
Comments are closed.